Xeris Biopharma Holdings Inc (XERS)
SG&A Expense Growth
14.85%
Quarterly · Period ending:
XERS SG&A Expense Growth
Latest reported14.85%period ending
Latest reported14.85%period ending
XERS Quarterly SG&A Growth (QoQ) (0.00% → 14.85%)
Latest values, visible window
High-resolution chart · PNG
XERS sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 14.8483% | |
| 11.8774% | |
| 2.245% | |
| 4.6539% | |
| 0.8519% | |
| 9.6639% | |
| -10.7407% | |
| 12.4422% | |
| 4.2027% | |
| 2.1614% | |
| 0.7536% | |
| -0.9247% | |
| 11.9923% | |
| -2.1888% | |
| -0.3885% | |
| 4.5689% | |
| -8.1558% | |
| -33.7142% | |
| 104.1794% | |
| 2.345% | |
| 35.9071% | |
| 5.9951% | |
| 9.1847% | |
| -6.5745% | |
| -18.3375% | |
| 4.6701% | |
| 38.7511% | |
| -0.9784% | |
| 20.0192% | |
| 43.4728% | |
| 87.6344% | |
| 3.3563% | |
| 38.9009% | |
| 4.5513% | |
| 53.5944% | |
| 29.3778% | |
| 16.2565% | |
| 0% |